AUPR921901A0 - Determining antibody specificity - Google Patents
Determining antibody specificityInfo
- Publication number
- AUPR921901A0 AUPR921901A0 AUPR9219A AUPR921901A AUPR921901A0 AU PR921901 A0 AUPR921901 A0 AU PR921901A0 AU PR9219 A AUPR9219 A AU PR9219A AU PR921901 A AUPR921901 A AU PR921901A AU PR921901 A0 AUPR921901 A0 AU PR921901A0
- Authority
- AU
- Australia
- Prior art keywords
- antibody specificity
- determining antibody
- determining
- specificity
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR9219A AUPR921901A0 (en) | 2001-11-30 | 2001-11-30 | Determining antibody specificity |
AU2002342412A AU2002342412A1 (en) | 2001-11-30 | 2002-11-26 | Determining antibody specificity |
PCT/AU2002/001596 WO2003046555A1 (en) | 2001-11-30 | 2002-11-26 | Determining antibody specificity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR9219A AUPR921901A0 (en) | 2001-11-30 | 2001-11-30 | Determining antibody specificity |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPR921901A0 true AUPR921901A0 (en) | 2001-12-20 |
Family
ID=3833028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPR9219A Abandoned AUPR921901A0 (en) | 2001-11-30 | 2001-11-30 | Determining antibody specificity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPR921901A0 (en) |
WO (1) | WO2003046555A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020500169A (en) * | 2016-10-27 | 2020-01-09 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | Compounds that neutralize influenza virus |
-
2001
- 2001-11-30 AU AUPR9219A patent/AUPR921901A0/en not_active Abandoned
-
2002
- 2002-11-26 WO PCT/AU2002/001596 patent/WO2003046555A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003046555A1 (en) | 2003-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002256895A1 (en) | Anti-TRAIL-R antibodies | |
EP1432444A4 (en) | Anti-a-beta antibodies | |
HK1074206A1 (en) | Anti-trail-r antibodies | |
AU2002351623A1 (en) | Streptococcus antigens | |
AU2002303384A1 (en) | Epitope-captured antibody display | |
AU2002365649A1 (en) | Anti-dota antibody | |
AU2002359392A1 (en) | Rapid prion-detection assay | |
AU2002353861A1 (en) | Assay | |
AU2001246934A1 (en) | Agonist antibodies | |
AUPR546801A0 (en) | Recombinant antibodies | |
AU2001232132A1 (en) | Novel assay | |
AU2001232041A1 (en) | Improved assay | |
AU2002221132A1 (en) | Novel antibody | |
AU2001267922A1 (en) | Method of assaying the function of fc fragment of antibody | |
AU2001240793A1 (en) | Novel assay | |
AUPR921901A0 (en) | Determining antibody specificity | |
AU2002342412A1 (en) | Determining antibody specificity | |
AU5240901A (en) | Assay | |
AU2001245781A1 (en) | Cd18-binding antibodies inhibit stenosis-related disorders | |
AU2002226584A1 (en) | Immobilised aptamers | |
AU2001295042A1 (en) | Anti-stilbene antibodies | |
AU3389501A (en) | Assay | |
AU2001276499A1 (en) | Assay | |
AU2002359980A1 (en) | Specific antibody for detecting bradeion | |
AU2002335264A1 (en) | Anti-HLA-DR antibody |